USA Cost Of Revenue vs Capex To Revenue Analysis

USAC Stock  USD 23.06  0.52  2.31%   
USA Compression financial indicator trend analysis is much more than just breaking down USA Compression Partners prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether USA Compression Partners is a good investment. Please check the relationship between USA Compression Cost Of Revenue and its Capex To Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USA Compression Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Cost Of Revenue vs Capex To Revenue

Cost Of Revenue vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of USA Compression Partners Cost Of Revenue account and Capex To Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between USA Compression's Cost Of Revenue and Capex To Revenue is -0.66. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of USA Compression Partners, assuming nothing else is changed. The correlation between historical values of USA Compression's Cost Of Revenue and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of USA Compression Partners are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Cost Of Revenue i.e., USA Compression's Cost Of Revenue and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

-0.66
Relationship DirectionNegative 
Relationship StrengthWeak

Cost Of Revenue

Cost of Revenue is found on USA Compression Partners income statement and represents the costs associated with goods and services USA Compression provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.
Most indicators from USA Compression's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into USA Compression Partners current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USA Compression Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, USA Compression's Sales General And Administrative To Revenue is projected to increase slightly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 3 B, whereas Tax Provision is forecasted to decline to about 775.9 K.
 2021 2022 2023 2024 (projected)
Interest Expense129.8M138.1M169.9M178.4M
Depreciation And Amortization238.8M236.7M246.1M141.4M

USA Compression fundamental ratios Correlations

0.870.940.93-0.290.980.730.890.33-0.21.00.31-0.20.980.950.890.830.26-0.290.850.730.96-0.490.940.110.83
0.870.890.94-0.270.930.850.970.36-0.290.860.17-0.290.880.930.970.870.5-0.270.950.850.93-0.520.83-0.230.82
0.940.890.96-0.290.950.790.940.2-0.40.930.13-0.40.980.950.940.850.3-0.290.920.770.97-0.630.95-0.050.88
0.930.940.96-0.330.960.860.980.43-0.350.920.13-0.350.940.950.980.880.44-0.330.970.850.97-0.570.9-0.20.81
-0.29-0.27-0.29-0.33-0.33-0.27-0.25-0.290.07-0.29-0.240.07-0.31-0.33-0.25-0.3-0.151.0-0.25-0.28-0.310.27-0.23-0.02-0.24
0.980.930.950.96-0.330.80.940.36-0.250.970.3-0.250.970.980.940.870.34-0.330.910.80.97-0.460.91-0.010.85
0.730.850.790.86-0.270.80.880.37-0.240.720.0-0.240.760.830.880.960.78-0.280.880.970.83-0.580.72-0.550.68
0.890.970.940.98-0.250.940.880.35-0.310.880.08-0.310.920.961.00.90.51-0.250.980.870.97-0.60.89-0.280.83
0.330.360.20.43-0.290.360.370.350.010.330.280.010.220.290.350.30.39-0.290.360.440.290.090.15-0.260.07
-0.2-0.29-0.4-0.350.07-0.25-0.24-0.310.01-0.19-0.051.0-0.31-0.27-0.3-0.2-0.070.07-0.42-0.33-0.290.22-0.270.19-0.18
1.00.860.930.92-0.290.970.720.880.33-0.190.33-0.190.980.940.880.830.25-0.280.840.720.95-0.480.940.120.83
0.310.170.130.13-0.240.30.00.080.28-0.050.33-0.050.210.210.080.07-0.15-0.240.070.10.130.270.10.470.1
-0.2-0.29-0.4-0.350.07-0.25-0.24-0.310.011.0-0.19-0.05-0.31-0.27-0.3-0.2-0.070.07-0.42-0.33-0.290.22-0.270.19-0.18
0.980.880.980.94-0.310.970.760.920.22-0.310.980.21-0.310.960.920.850.27-0.310.890.750.98-0.570.960.060.86
0.950.930.950.95-0.330.980.830.960.29-0.270.940.21-0.270.960.960.90.4-0.330.940.830.99-0.550.92-0.090.85
0.890.970.940.98-0.250.940.881.00.35-0.30.880.08-0.30.920.960.90.51-0.250.980.870.97-0.60.89-0.280.83
0.830.870.850.88-0.30.870.960.90.3-0.20.830.07-0.20.850.90.90.71-0.30.880.950.9-0.640.83-0.380.77
0.260.50.30.44-0.150.340.780.510.39-0.070.25-0.15-0.070.270.40.510.71-0.160.50.80.41-0.40.25-0.80.25
-0.29-0.27-0.29-0.331.0-0.33-0.28-0.25-0.290.07-0.28-0.240.07-0.31-0.33-0.25-0.3-0.16-0.25-0.29-0.310.27-0.23-0.02-0.24
0.850.950.920.97-0.250.910.880.980.36-0.420.840.07-0.420.890.940.980.880.5-0.250.880.94-0.60.86-0.340.78
0.730.850.770.85-0.280.80.970.870.44-0.330.720.1-0.330.750.830.870.950.8-0.290.880.82-0.570.71-0.540.65
0.960.930.970.97-0.310.970.830.970.29-0.290.950.13-0.290.980.990.970.90.41-0.310.940.82-0.60.94-0.10.85
-0.49-0.52-0.63-0.570.27-0.46-0.58-0.60.090.22-0.480.270.22-0.57-0.55-0.6-0.64-0.40.27-0.6-0.57-0.6-0.720.35-0.61
0.940.830.950.9-0.230.910.720.890.15-0.270.940.1-0.270.960.920.890.830.25-0.230.860.710.94-0.720.010.89
0.11-0.23-0.05-0.2-0.02-0.01-0.55-0.28-0.260.190.120.470.190.06-0.09-0.28-0.38-0.8-0.02-0.34-0.54-0.10.350.01-0.01
0.830.820.880.81-0.240.850.680.830.07-0.180.830.1-0.180.860.850.830.770.25-0.240.780.650.85-0.610.89-0.01
Click cells to compare fundamentals

USA Compression Account Relationship Matchups

USA Compression fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets3.7B2.9B2.8B2.7B2.7B2.1B
Short Long Term Debt Total1.9B1.9B2.0B2.1B2.4B1.3B
Other Current Liab116.2M109.5M113.9M76.0M85.1M53.2M
Total Current Liabilities189.4M170.3M187.6M173.7M187.5M108.4M
Total Stockholder Equity1.7B815.0M578.4M(116.3M)183.0M173.9M
Property Plant And Equipment Net2.5B2.4B2.2B2.2B2.3B1.6B
Current Deferred Revenue48.3M47.2M51.2M62.3M62.6M65.7M
Net Debt1.9B1.9B2.0B2.1B2.4B1.2B
Accounts Payable21.7M13.5M22.5M35.3M39.8M23.6M
Cash10K2K(18.6M)35K11K11.6K
Non Current Assets Total3.5B2.7B2.6B2.5B2.5B2.0B
Non Currrent Assets Other15.6M12.0M16.1M13.1M9.7M15.6M
Cash And Short Term Investments10K2K(18.6M)35K11K11.6K
Net Receivables136.8M112.5M113.2M83.9M95.4M63.3M
Common Stock Shares Outstanding96.6M96.8M97.1M97.8M100.7M70.0M
Liabilities And Stockholders Equity3.7B2.9B2.8B2.7B2.7B1.6B
Non Current Liabilities Total1.9B2.0B2.0B2.1B2.4B1.2B
Inventory91.9M84.6M85.8M93.8M114.7M120.5M
Other Current Assets2.2M2.4M6.0M8.8M16.3M17.1M
Other Stockholder Equity1.7B815.0M578.4M(125.1M)(293.3M)(278.6M)
Total Liab2.1B2.1B2.8B2.8B2.6B1.4B
Property Plant And Equipment Gross2.5B2.4B3.6B3.8B4.0B4.2B
Total Current Assets230.9M199.6M205.0M186.4M226.4M117.2M
Accumulated Other Comprehensive Income(689.9M)(821.5M)14.0M8.8M7.9M8.3M
Intangible Assets363.2M333.8M304.4M275.0M245.7M201.3M
Net Tangible Assets675.3M481.2M274.0M86.0M77.4M73.5M
Retained Earnings(1.7B)(815.0M)(578.4M)(18.4M)(16.6M)(17.4M)
Other Assets15.6M34.7M16.1M13.1M15.1M12.1M
Long Term Debt1.9B1.9B2.0B2.1B2.3B1.5B
Long Term Debt Total1.9B1.9B2.0B2.1B2.4B1.4B
Common Stock1.2B323.7M87.1M(125.1M)(112.6M)(107.0M)
Property Plant Equipment2.5B2.4B2.2B2.2B2.5B2.0B
Other Liab11.9M14.2M9.2M7.0M8.1M7.0M
Non Current Liabilities Other30.8M36.5M28.7M8.3M10.9M17.5M
Net Invested Capital3.5B2.7B101.1M2.5B2.5B1.9B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether USA Compression Partners offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USA Compression's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usa Compression Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usa Compression Partners Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USA Compression Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USA Compression. If investors know USA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USA Compression listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.44
Dividend Share
2.1
Earnings Share
0.55
Revenue Per Share
8.525
Quarterly Revenue Growth
0.105
The market value of USA Compression Partners is measured differently than its book value, which is the value of USA that is recorded on the company's balance sheet. Investors also form their own opinion of USA Compression's value that differs from its market value or its book value, called intrinsic value, which is USA Compression's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USA Compression's market value can be influenced by many factors that don't directly affect USA Compression's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USA Compression's value and its price as these two are different measures arrived at by different means. Investors typically determine if USA Compression is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USA Compression's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.